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Pathophysiology
The pathogenesis of IIH remains elusive, despite many theories emerging from neuroradiologic research and studies of cerebrospinal fluid (CSF) hydrodynamics (Table 2) . (15) The absence of an increase in ventricular size despite the raised ICP in this disease also is puzzling.
Vision loss in IIH is believed to be caused by transmission of high ICP to the optic nerve head (ONH). Damage may result from axoplasmic stasis and microvascular compromise.
Early vision loss may be caused by macular edema, subretinal or perimacular hemorrhages, and anterior ischemic optic neuropathy. (17) (18) 
Differential Diagnosis
IIH is a diagnosis of exclusion. Following the Dandy criteria, by definition there should be no other identifiable neurologic disease. Numerous associations with IIH have been described (Table 3) , and any of these related variables and potential causes of increased ICP must be excluded. Nomenclature dictates that identifiable causative factors be excluded from the diagnosis of IIH and be referred to, instead, as secondary causes of intracranial hypertension. However, many different "associations" with IIH are cited in the literature, and although many are well documented, others are based on anecdotal case reports or small case series. Pediatric ICP very often is found in association with an underlying causative factor, (40) such as ear infection, dural sinus thrombosis, steroid withdrawal, malnutrition associated with refeeding, hypervitaminosis A, minocycline, and others. (3)(9)(10)(12)(40)(41)(42)(43) It is very important to exclude any of these associated conditions or causative factors prior to commencing therapy. (44) Optic nerve drusen can be confused with papilledema. Drusen are the most common causes of disc elevation, and confirming their presence may be challenging, more so in children because drusen tend to locate deeply in the ONH at a young age, only becoming more visible later in life. (11)(45)(46) Lorentzen (47) reported the prevalence of optic nerve drusen at 0.34%, increasing by a factor of 10 in relatives of affected individuals. Although most patients who have drusen never develop visual symptoms, some have visual field abnormalities as a result of axonal compression. Fortunately, other complications, such as ischemic optic neuropathy and peripapillary neovascular membranes, are rare.
Clinical Evaluation History
Headache is the most common symptom of IIH in both children and adults. (9)(12)(41)(42) As with most headaches induced by elevated ICP, they may be worse in the morning, awaken the patient from sleep, or increase with a Valsalva maneuver. The headaches can be accompanied by nausea and vomiting. Ophthalmic symptoms, such as decreased and blurred vision, diplopia, and transient visual obscurations, also are reported frequently. (12) Transient visual obscurations are, in our experience, relatively frequent in older children but rarely reported on routine questioning. The obscurations probably result from transient ischemia of the ONH and are elicited most often by changes in posture. The obscurations can be uni-or bilateral and last only a few seconds. The clinical picture in younger children and infants deserves special attention because the most notable findings may be irritability, (48) apathy, and somnolence. (10) (44) Other nonspecific neurologic manifestations can be encountered, including ataxia, dizziness, neck/shoulder/ (54) ONH drusen (Figs. 2 and 3) can elevate the disc and blur its margins in a manner that may be difficult to distinguish from papilledema. It is unusual, but the two can coexist. (55) In true papilledema, however, the vessels are obscured at the disc margins, the elevation extends into the retina surrounding the disc, venous congestion is present, and exudates may be present. (11)(45)(56) The presence of spontaneous venous pulsations at the ONH usually indicates that the ICP is less than 200 mm H 2 O. (57) This sign is only useful if the pulsations are seen because they can be absent in the normal population. Optic disc hemorrhages suggest papilledema but also can be seen with optic nerve drusen. Funduscopy and examination for these findings should be sufficient to diagnose papilledema in most cases, but detection may prove difficult in children.
Loss of visual acuity more commonly is a late finding in IIH. Looking for other ways to assess optic nerve function, therefore, is critical. The presence of a relative afferent pupillary defect or a color vision deficit indicates optic neuropathy, but should not be the only parameters examined.
Uni-or bilateral sixth nerve palsy is frequent (40% to 48%) in children who have IIH, (9)(10)(12)(43) and the incidence seems to be higher in children than in adults. Third and fourth nerve paresis can be seen but is much less common. (6)(15) 
Investigations Imaging Studies
Magnetic resonance imaging (MRI) and magnetic resonance venography (MRV) are, at present, the imaging studies of choice for detecting IIH. Neuroimaging is mandatory not only to exclude the possibility of herniation prior to a lumbar puncture but to identify potential secondary causes of elevated ICP. MRI is superior to computed tomography (CT) scan in detecting a sinus or venous thrombosis, certain malignancies, gliomatosis cerebri, and meningeal abnormalities. (13)(52)(60)(61) In atypical patients (slim patients, children, and men), MRV should be considered. (3) Neuroimaging results should be normal in IIH except for signs of ICP. The ventricles should be of normal to small size, and the following signs of raised ICP may be found: flattening of the posterior sclera (Fig. 4) , empty sella (Fig. 5) , distention of the perioptic subarachnoidal space (Fig. 4) , enhancement of the prelaminar optic nerve, vertical tortuosity of the orbital optic nerve, and intraocular protrusion of the prelaminar optic nerve. (62)(63)
Ancillary Ophthalmologic Tests
When trying to differentiate papilledema from buried ONH drusen, CT scan (Fig. 6 ) and ultrasonography are useful tools that can demonstrate calcification of the Fluorescein angiography seldom is necessary but may be performed with a cooperative child. Papilledema causes dye leakage; drusen are autofluorescent and cause no leakage. An increasingly prevalent technique in ophthalmology-confocal scanning laser tomography with the Heidelberg Retinal Tomograph (HRT)-appears to be useful in distinguishing pseudoedema from true papilledema. The procedure does so by quantifying disc elevation above the retinal surface, which is greater and extends beyond the disc margin in true papilledema. (68) The clinical value of HRT in children who have IIH as well as how it compares with other examination techniques remains unknown.
Visual field testing is extremely important in the management of IIH. Visual field evaluations are statistically more sensitive than visual acuity and contrast sensitivity testing in the detection of worsening disease. (69) The most commonly reported visual field defect is an enlarged (often reversibly) blind spot due to papilledema. (70) Other reported visual field abnormalities include arcuate defects, inferonasal visual field loss, global constriction, generalized depression, and cecocentral scotomas, all of which can be permanent. (69)(70)(71) Recording the visual field (with either Humphrey or Goldmann perimetry) in a pediatric patient can be challenging and requires full cooperation. Such cooperation generally can be achieved by 7 years of age, but younger children sometimes do surprisingly well.
Fundus photography can be useful for monitoring optic nerve and fundus changes during follow-up. Visual evoked potentials are insensitive to visual loss in IIH. (72) 
CSF Pressure
A lumbar puncture in a patient who has IIH should display an increased CSF opening pressure as well as a normal cell count, normal glucose concentration, normal or low protein content, and the absence of infection. (75)(76) Moreover, ICP in the normal range does not exclude IIH because of diurnal fluctuations in CSF pressure. In these circumstances, repeating the lumbar puncture may be considered. Although prolonged pressure monitoring has been advocated, (15) it is invasive and does not mimic normal physiologic conditions. (74) Furthermore, Eide (77) recently showed that the quality of continuous ICP recordings in children is prone to error.
Management
Management of IIH is based almost entirely on clinical experience, due largely to the absence of randomized prospective trials that allow for evidence-based recommendations. (3)(15)(52) The goal of treatment is to relieve symptoms and to normalize ICP to preserve vision. (3)(52) Asymptomatic patients who have normal vision and minimal papilledema may be monitored closely without treatment. (3)(16) Follow-up should be particularly attentive in children, in whom ocular examination and visual field evaluation often are difficult or unreliable. When treatment is necessary, medications are sufficient in most patients. Surgery should be considered for progressive vision loss despite maximum medical therapy, if there is severe visual loss or rapid progression at presentation, and when severe papilledema causes exudation and macular edema. (9)(11)(16)(52)(78) The surgical options are optic nerve sheath decompression (ONSD) or CSF shunting procedures.
Any potential precipitating factors should be removed. Weight loss is a time-honored treatment and should be advised when appropriate. (3)
Medical
Acetazolamide, a sulfa-derived diuretic and carbonic anhydrase inhibitor that reduces CSF production, often is used as the first-line therapeutic agent for IIH. The starting dose recommended in children is 25 mg/kg per day, which may be increased to 100 mg/kg per day (maximum, 2 g/d). (11) Well-recognized adverse effects of acetazolamide include gastrointestinal upset, metallic taste, tingling of the lips and digits, loss of appetite, electrolyte imbalances, metabolic acidosis, and nephrocalcinosis. (19) Acetazolamide is contraindicated in the presence of sulfonamide allergy and significant renal or liver disease.
Furosemide, a loop diuretic, can be used in combination with or as an alternative to acetazolamide if there is an intolerance of or contraindication to this drug. The effect of furosemide on CSF production is weaker than that of acetazolamide. (79) The most common adverse effects are electrolyte imbalances, dehydration, and hypotension. The risk of hypokalemia increases when diuretics are combined. The suggested dose of furosemide is 1 mg/kg per day.
Corticosteroids can be useful in the management of IIH but should be administered with caution. Corticosteroid withdrawal is associated with an elevation of ICP. (80)(81) The adverse effects of corticosteroids are numerous and well documented and include weight gain, which could be deleterious for IIH. Steroids have been used in conjunction with diuretics to treat children whose response to diuretics is poor. (11)(79) More commonly, steroids are used to treat rapid visual deterioration while patients are awaiting surgery.
Some patients have been cured by the diagnostic lumbar puncture. (13) Information on ONSD to treat pediatric IIH is limited. Pediatric case series suggest that ONSD is a safe and effective method of stabilizing visual acuity and visual field loss in children. (78)(88)(89) It is unclear whether the therapeutic effect is due to a filtration bleb effect or to the proliferation of fibroblasts around the optic nerve causing obstruction and preventing further passage of CSF distal to the operative site. (90)(91)(92)(93)(94) 
Prognosis and Follow-up
Little is known about the natural history of IIH. Although earlier literature suggested a good visual prognosis in pediatric IIH, it now is clear that vision loss can be permanent. This condition should be recognized as a potential cause of visual impairment. Baker and associates (43) found moderate visual impairment or worse in 17% of 36 children who had experienced IIH, a finding confirmed by other case series. (9)(12)(101) The course of IIH often is protracted. Close surveillance of affected children is vital because vision loss can occur at presentation, during treatment, or following recurrences. Due to the sometimes conflicting and entirely retrospective analyses of risk factors for this condition, interpretation of their role in the disease process remains difficult. (3)(9)(102) Although high-grade papilledema is associated with vision loss, the disc appearance cannot be used to predict final visual outcome. (53)(54) Recent weight gain, subretinal hemorrhage, significant visual field loss at presentation, and hypertension also have been identified as predictors of vision loss in IIH. (3) Close follow-up includes evaluation of visual acuity, color vision, pupillary function, and visual fields. Fundus photographs are useful because they allow comparison over the course of the disease. In the absence of conclusive evidence, arbitrary guidelines as to the frequency of follow-up have been proposed. Shin and Balcer (19) suggest follow-up at 1-month intervals for 6 to 12 months and then less frequently once the disease has stabilized. Kesler and associates (103) suggest follow-up visits for a minimum of 5 years on the basis of disease recurrence in almost 40% of patients. Strong data regarding optimum follow-up in children who have IIH do not exist.
Summary
The demographics of IIH differ between children and adults. IIH appears to affect boys and girls equally until puberty, when it becomes more frequent in girls, as it is in adult women. The association of IIH with obesity is lesser in children, but this relationship increases with age. The clinical presentation of IIH in children differs significantly from that of adults, and its identification is crucial because it can cause permanent visual impairment. A high degree of suspicion is necessary to establish the diagnosis of IIH in infants and young children, who are more difficult to examine and whose signs and symptoms often are substantially different from those of adults. Data on medical and surgical treatment of this disease are scarce, with management based largely on clinical experience. Despite the apparent efficacy of current therapies, further prospective, randomized trials are necessary to define treatment guidelines and maximize follow-up. Close surveillance and interdisciplinary management of pediatric IIH is recommended to optimize the treatment of this potentially blinding disorder.
